Medi-Caps (BOM:523144) Tariff Resilience Score: 0/10 (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:523144 Medi-Caps Ltd BOM:523144
47 GF Score
Price ₹25.84
GF Value ₹19.65
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Medi-Caps Tariff Resilience Score?

Medi-Caps has the Tariff Resilience Score of 0, which implies that the company might have .

Medi-Caps has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Medi-Caps might have .

Medi-Caps  (BOM:523144) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Medi-Caps Tariff Resilience Score Related Terms

BOM:523144
47GF Score
Medi-Caps Ltd BOM:523144
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medi-Caps (BOM:523144) Overvalued in 2026?

Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued. The current stock price of ₹25.84 is trading 31.5% above its estimated GF Value™ of ₹19.65. GuruFocus considers Medi-Caps to be Significantly Overvalued.

Key valuation signals for BOM:523144:

  • Tariff Resilience Score: 0
  • GF Value™: ₹19.65 vs. price of ₹25.84 (31.5% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:523144 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medi-Caps Business Description

Address 201, Pushpratna Paradise, 9/5, New Palasia, Opposite UCO Bank, Indore, MP, IND, 452 001
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
47GF Score

Get the complete analysis for BOM:523144

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.84
Price
₹19.65
GF Value